Home > Products > CD3 & IGF1R
> Recombinant Anti-CD3 x Anti-IGF1R Bispecific Antibody (Minibody)
Recombinant Anti-CD3 x Anti-IGF1R Bispecific Antibody (Minibody) (CAT#: MiniB-092)
Recombinant Anti-CD3 x Anti-IGF1R Bispecific Antibody (Minibody) is designed to be expressed as the anti-CD3 scFv fused to N-terminus of Knob-CH3 domain and the anti-IGF1R scFv to the Hole-CH3 domain, or vice versa. The CH3 domains are further stabilized by C-terminal disulfide bonds. This BsAb can retarget T cells to tumor cells. It is designed for the research of Melanoma; Colon cancer; Pancreas cancer; Prostate cancer; Kidney cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-IGF1R Bispecific Antibody (Minibody) (MiniB-092). Click the button below to contact us or submit your feedback about this product.